Oligonucleotide primers for detecting the presence of markers associated with resistance to blackleg disease (Plenodomus spp.) in the genome of winter oilseed rape (Brassica napus L.) and a method for detecting these markers

PL452021A1Pending Publication Date: 2026-11-16UNIV PRZYRODNICZY W POZNANIU
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PL2025452021
Authority / Receiving Office
PL · PL
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-12
Publication Date
2026-11-16

Smart Images

  • Figure 00000015_0000
    Figure 00000015_0000
  • Figure 00000015_0001
    Figure 00000015_0001
  • Figure 00000015_0002
    Figure 00000015_0002
Patent Text Reader

Abstract

Oligonucleotide primers for detecting markers 4899, 5564 and 5781 associated with resistance to blackleg (Plenodomus spp.) in the genome of winter oilseed rape Brassica napus L. with sequences no. 7, 8 and 9, as presented in the sequence listing, wherein to detect the presence of a. marker 4899 - nucleotide sequences 1 and 2 are used, b. marker 5564 - nucleotide sequences 3 and 4 are used, c. marker 5781 - nucleotide sequences 5 and 6 are used. A method for identifying markers 4899, 5564 and 5781, allowing for the selection of plants having these markers, comprising the following steps: a. winter oilseed rape seedlings are grown on a culture medium for 7 days, b. DNA is isolated from winter rapeseed leaves, c.the presence of the appropriate marker is analyzed using the polymerase chain reaction (PCR), where the primer sequences presented in the sequence list are used in such a way that: - for marker 4899 - nucleotide sequences 1 and 2 are used, - for marker 5564 - nucleotide sequences 3 and 4 are used, - for marker 5781 - nucleotide sequences 5 and 6 are used, d. the PCR product is separated in an agarose gel and then the gel is documented in a transilluminator, e. based on the image of the gel from the transilluminator, the rapeseed genotypes with the appropriate marker are identified by identifying the rapeseed DNA samples on the matrix of which the PCR product was most efficiently formed.
Need to check novelty before this filing date? Find Prior Art